Staszewsky, Lidia <br/><br/>
Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.  [electronic resource] 

 -  European journal of heart failure  07 2016 
 - 840-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0844 
<br/><br/><label>Standard No.: </label>10.1002/ejhf.519  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Adrenergic beta-Agonists<br/>Adrenergic beta-Antagonists--therapeutic use<br/>Aged<br/>Aged, 80 and over<br/>Angiotensin Receptor Antagonists--therapeutic use<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Anti-Arrhythmia Agents--therapeutic use<br/>Anticoagulants--therapeutic use<br/>Bronchodilator Agents--therapeutic use<br/>Calcium Channel Blockers--therapeutic use<br/>Cardiac Resynchronization Therapy<br/>Cholinergic Antagonists<br/>Cohort Studies<br/>Digitalis Glycosides<br/>Diuretics--therapeutic use<br/>Female<br/>Heart Failure--complications<br/>Hospitalization<br/>Humans<br/>Hypolipidemic Agents<br/>Information Storage and Retrieval<br/>Male<br/>Middle Aged<br/>Mineralocorticoid Receptor Antagonists--therapeutic use<br/>Mortality<br/>Multivariate Analysis<br/>Nitrates<br/>Patient Readmission--statistics & numerical data<br/>Platelet Aggregation Inhibitors<br/>Proportional Hazards Models<br/>Pulmonary Disease, Chronic Obstructive--complications<br/>Treatment Outcome<br/>Xanthines--therapeutic use